3.8 Article

The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Chasing the storm: Recruiting non-hospitalized patients for a multi-site randomized controlled trial in the United States during the COVID-19 pandemic

Kelly Hu et al.

Summary: Randomized controlled trials (RCTs) are crucial for evaluating clinical interventions, but inadequate recruitment can be a major challenge, especially during a pandemic. Strategies such as transparency, education, financial incentives, and partnerships with testing sites can help improve recruitment rates.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)

Article Medicine, General & Internal

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

A. Jayk Bernal et al.

Summary: This study found that early treatment with molnupiravir reduced the risk of hospitalization or death in at-risk, unvaccinated adults with Covid-19.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

Jennifer Hammond et al.

Summary: In high-risk, unvaccinated adults, treatment of Covid-19 with nirmatrelvir plus ritonavir can significantly reduce the risk of hospitalization and death, with good safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Population Immunity and Covid-19 Severity with Omicron Variant in South Africa

Shabir A. Madhi et al.

Summary: The Omicron variant of SARS-CoV-2 spread more rapidly in South Africa, where two thirds of unvaccinated residents were found to have past infections. Omicron peaked just 1 month after being detected, with hospitalizations and deaths not increasing proportionately with the rise in cases. It remains unclear whether this change is due to widespread preexisting immunity or unique features of the virus.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Computer Science, Artificial Intelligence

Cure models to estimate time until hospitalization due to COVID-19 A case study in Galicia (NW Spain)

Maria Pedrosa-Laza et al.

Summary: This study provides a brief overview of survival analysis and censored data, conducts a thorough literature review on cure models, and applies main nonparametric and semiparametric methods to a dataset of COVID-19 patients, showing the influence of age and sex on time to hospital admission.

APPLIED INTELLIGENCE (2022)

Article Public, Environmental & Occupational Health

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial

Gilmar Reis et al.

Summary: Treatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19 reduced the need for hospitalisation defined as retention in a COVID-19 emergency setting or transfer to a tertiary hospital. The trial showed a higher probability of superiority (99.8%) surpassing the prespecified threshold of 97.6%.

LANCET GLOBAL HEALTH (2022)

Article Medicine, General & Internal

COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022

Fiona P. Havers et al.

Summary: Understanding the factors that contribute to hospitalization in vaccinated individuals is crucial for combating COVID-19. This study found that unvaccinated adults were more likely to be hospitalized compared to vaccinated adults, with the lowest hospitalization rates observed in those who had received a booster dose.

JAMA INTERNAL MEDICINE (2022)

Article Respiratory System

Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?

Dominic L. Sykes et al.

Summary: Recent studies have shown that COVID-19 patients may experience lasting symptoms, with females being more likely to report residual symptoms. The phenomenon of Long-COVID may not be solely attributed to the impact of SARS-CoV-2, indicating a potential role of biopsychosocial effects of COVID-19 in its etiology.
News Item Medicine, General & Internal

Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Medicine, General & Internal

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Ly-Mee Yu et al.

Summary: The study found that inhaled budesonide can reduce recovery time and potentially decrease the risk of hospital admissions or deaths among high-risk COVID-19 patients in the community.

LANCET (2021)

Article Critical Care Medicine

International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019

Nicole Evangelidis et al.

CRITICAL CARE MEDICINE (2020)

Review Medicine, General & Internal

Drug treatments for covid-19: living systematic review and network meta-analysis

Reed A. C. Siemieniuk et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Review Medicine, General & Internal

Current Understanding of COVID-19 Clinical Course and Investigational Treatments

Richard B. Aguilar et al.

FRONTIERS IN MEDICINE (2020)

Letter Medical Informatics

A real-time dashboard of clinical trials for COVID-19

Kristian Thorlund et al.

LANCET DIGITAL HEALTH (2020)

Article Statistics & Probability

Sample size calculation for a proportional hazards mixture cure model with nonbinary covariates

Yihong Zhan et al.

JOURNAL OF APPLIED STATISTICS (2019)

Article Medicine, General & Internal

Validity of composite end points in clinical trials

VM Montori et al.

BMJ-BRITISH MEDICAL JOURNAL (2005)